Savient (Nasdaq: SVNT) Creditor Tang Loses Bid to Bar Debt Deal
Posted on May 08, 2012 at 10:47 AM EDT
Atlanta, Ga 5/8/12 (StreetBeat) – Savient Pharmaceuticals Inc. (Nasdaq: SVNT), maker of the gout medicine Krystexxa, defeated a creditor’s bid for a court order blocking a debt transaction, allowing it to raise about $44 million and extend ...
